Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Weibo
WB
$1.87B
| $4.58M | 0.01% |
418,300
-26,700
| -6% | -$303K |
|
1402
Orthofix Medical
OFIX
$418M
| $4.57M | 0.01% |
339,318
-186,418
| -35% | -$2.19M |
|
1403
Gran Tierra Energy
GTE
$332M
| $4.57M | 0.01% |
810,180
+102,000
| +14% | +$634K |
|
1404
RLI Corp
RLI
$5.85B
| $4.57M | 0.01% |
68,600
-13,200
| -16% | -$886K |
|
|
SCX
1405
DELISTED
The L.S. Starrett Company
SCX
| $4.57M | 0.01% |
377,239
+10,016
| +3% | +$105K |
|
1406
Alector
ALEC
$226M
| $4.56M | 0.01% |
571,983
+69,780
| +14% | +$413K |
|
1407
Atea Pharmaceuticals
AVIR
$410M
| $4.56M | 0.01% |
1,496,303
+141,762
| +10% | +$429K |
|
1408
American Well
AMWL
$218M
| $4.56M | 0.01% |
152,940
+45,220
| +42% | +$1.11M |
|
1409
Center Bancorp
CNOB
$1.79B
| $4.55M | 0.01% |
198,816
-104,471
| -34% | -$2.01M |
|
1410
TriMas Corp
TRS
$1.4B
| $4.55M | 0.01% |
179,700
+94,530
| +111% | +$2.34M |
|
1411
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
| $4.54M | 0.01% |
83,900
+52,000
| +163% | +$2.67M |
|
1412
GlobalFoundries
GFS
$29.4B
| $4.53M | 0.01% |
74,800
+27,500
| +58% | +$1.52M |
|
1413
SPDR Gold MiniShares Trust
GLDM
$30B
| $4.53M | 0.01% |
+110,800
| New | +$4.34M |
|
1414
Tidal Trust II Defiance Nasdaq 100 Weekly Distribution ETF
QQQY
$189M
| $4.52M | 0.01% |
+85,200
| New | +$4.65M |
|
1415
Fluence Energy
FLNC
$2.43B
| $4.52M | 0.01% |
+189,400
| New | +$3.99M |
|
1416
Integra LifeSciences
IART
$1.42B
| $4.51M | 0.01% |
+103,560
| New | +$4.08M |
|
1417
Interparfums
IPAR
$3.68B
| $4.51M | 0.01% |
31,300
+7,787
| +33% | +$1.02M |
|
1418
Elanco Animal Health
ELAN
$11.8B
| $4.49M | 0.01% |
+301,244
| New | +$3.41M |
|
|
FBRT
1419
Franklin BSP Realty Trust
FBRT
$669M
| $4.48M | 0.01% |
331,900
-47,600
| -13% | -$627K |
|
1420
Regency Centers
REG
$14.1B
| $4.48M | 0.01% |
66,877
-64,391
| -49% | -$3.98M |
|
|
CMA
1421
DELISTED
Comerica
CMA
| $4.47M | 0.01% |
80,147
-346,500
| -81% | -$15.7M |
|
1422
Home Bancorp
HBCP
$568M
| $4.47M | 0.01% |
106,473
-1,400
| -1% | -$51.2K |
|
1423
Evercore
EVR
$11.9B
| $4.46M | 0.01% |
26,100
-40,900
| -61% | -$5.92M |
|
1424
Northwest Natural Holdings
NWN
$2.14B
| $4.46M | 0.01% |
114,600
+42,200
| +58% | +$1.6M |
|
1425
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$196M
| $4.46M | 0.01% |
150,700
+83,800
| +125% | +$3.44M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.